Home

Solution

Solution

Navigating the Gray Area Between HER2 Low and HER2 Negative Status

Distinguishing HER2-Low from HER2-Negative status

Navigating the Gray Area Between HER2 Low and HER2 Negative Status

Navigating the Gray Area Between HER2 Low and HER2 Negative Status

Improve diagnostic accuracy in breast cancer with Celnovte’s HER2 solutions. Our sensitive antibodies and automated stainers clarify the HER2-low gray area.

EBER ISH vs. EBV IHC: Which Method Provides the Most Accurate Gastric Cancer Diagnosis

Comparing EBER ISH and EBV IHC for gastric cancer diagnosis

EBER ISH vs. EBV IHC: Which Method Provides the Most Accurate Gastric Cancer Diagnosis

EBER ISH vs. EBV IHC: Which Method Provides the Most Accurate Gastric Cancer Diagnosis

Discover why EBER ISH outperforms IHC for Gastric Cancer diagnosis. Explore Celnovte’s Super-ISH™ probes and CNT 360 for high-precision EBV detection.

Enhancing Early Screening: Why Automated LBC Staining is the Next Step in Cytopathology

Automatic LBC stainers make laboratory work more efficient and reliable

Enhancing Early Screening: Why Automated LBC Staining is the Next Step in Cytopathology

Enhancing Early Screening: Why Automated LBC Staining is the Next Step in Cytopathology

Celnovte automated LBC staining systems boost efficiency, precision, and accuracy in cervical cancer screening, offering faster results and reliable diagnoses.

Beyond Conventional Polymers: How MicroStacker™ Technology is Redefining IHC Sensitivity

MicroStacker™ Technology is Redefining IHC Sensitivity

Beyond Conventional Polymers: How MicroStacker™ Technology is Redefining IHC Sensitivity

Beyond Conventional Polymers: How MicroStacker™ Technology is Redefining IHC Sensitivity

MicroStacker™ technology enhances IHC sensitivity, reduces background noise, and improves antigen detection, making it ideal for tumors and complex diagnostics.